About NeoGenomics

We provide our pharma and biotech partners with unparalleled expertise. By unifying our existing testing solutions with custom capabilities, including companion diagnostics, and by leveraging our data insights, we support the discovery through the commercialization of novel therapeutic drugs.

Cancer's questions occupy every moment of our days. Why? Because we know that every minute we spend consumed by answers, might mean one more life saved. Since we started in 1999, we have grown to an inspiring team of 2,200 worldwide, spanning 13 locations across two continents, with more than 120 MDs and PhDs on our staff.

With an ever-expanding portfolio of solutions, each year we deliver over 3.2 million cancer-related tests, including more than 100,000 NGS tests, and we work with more than 4,400 medical sites ─ providing answers to more than 600,000 patients.

Request a meeting during the show with one of our experts or to receive a copy of the posters.

*Not affiliated with or endorsed by AACR